Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders.
- Published in:
- Psychopharmacology Bulletin, 2004, v. 38, p. 14
- By:
- Publication type:
- Article
Works matching IS 00485764 AND DT 2004 AND VI 38
Results: 8
1
2
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics.
- Published in:
- Psychopharmacology Bulletin, 2004, v. 38, p. 6
- By:
- Publication type:
- Article
3
Panel Discussion.
- Published in:
- Psychopharmacology Bulletin, 2004, v. 38, p. 46
- Publication type:
- Article
4
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics.
- Published in:
- Psychopharmacology Bulletin, 2004, v. 38, p. 38
- By:
- Publication type:
- Article
5
Unmet Needs in the Treatment of Anxiety Disorders.
- Published in:
- Psychopharmacology Bulletin, 2004, v. 38, p. 31
- By:
- Publication type:
- Article
6
Understanding Psychiatric Disorders Through Functional Brain Imaging.
- Published in:
- Psychopharmacology Bulletin, 2004, v. 38, p. 21
- By:
- Publication type:
- Article
7
Late-Life Anxiety Disorders.
- Published in:
- Psychopharmacology Bulletin, 2004, v. 38, p. 25
- By:
- Publication type:
- Article
8
Studying Non-Human Primates: A Gateway to Understanding Anxiety Disorders.
- Published in:
- Psychopharmacology Bulletin, 2004, v. 38, p. 8
- By:
- Publication type:
- Article